Public Employees Retirement System of Ohio Takes $4.32 Million Position in Globe Life Inc. $GL

Public Employees Retirement System of Ohio acquired a new position in Globe Life Inc. (NYSE:GL) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 24,173 shares of the company’s stock, valued at approximately $4,319,000.

Other institutional investors also recently bought and sold shares of the company. Hilton Head Capital Partners LLC bought a new stake in shares of Globe Life during the 4th quarter valued at about $30,000. Johnson Financial Group Inc. bought a new stake in Globe Life during the second quarter valued at approximately $39,000. CYBER HORNET ETFs LLC purchased a new stake in Globe Life during the second quarter valued at approximately $28,000. MUFG Securities EMEA plc bought a new position in Globe Life in the second quarter worth approximately $31,000. Finally, AdvisorNet Financial Inc boosted its stake in shares of Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after acquiring an additional 92 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Globe Life Stock Performance

NYSE:GL opened at $176.34 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55. The stock has a 50-day moving average price of $178.65 and a 200 day moving average price of $160.50. The stock has a market capitalization of $13.55 billion, a P/E ratio of 11.71 and a beta of 0.46.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period last year, the business earned $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities research analysts forecast that Globe Life Inc. will post 15.71 EPS for the current fiscal year.

Globe Life announced that its board has initiated a share buyback program on Monday, August 10th that permits the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization permits the company to buy up to 17.7% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Monday, October 5th. Globe Life’s payout ratio is currently 8.76%.

Insiders Place Their Bets

In other news, CEO Frank M. Svoboda sold 10,000 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the completion of the transaction, the chief executive officer owned 54,020 shares in the company, valued at $9,004,053.60. This trade represents a 15.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO James Darden sold 50,000 shares of Globe Life stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $182.43, for a total value of $9,121,500.00. Following the completion of the sale, the chief executive officer directly owned 58,451 shares in the company, valued at $10,663,215.93. This trade represents a 46.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 151,908 shares of company stock worth $27,239,981. 2.11% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages recently commented on GL. Wells Fargo & Company raised their target price on Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. JPMorgan Chase & Co. raised their price objective on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Jefferies Financial Group boosted their price objective on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. Keefe, Bruyette & Woods decreased their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research note on Friday, July 24th. Finally, Morgan Stanley upped their price target on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $191.67.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.